In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

Julian A. Marin-Acevedo; Razvan M. Chirila; Roxana Dronca

doi:10.1016/j.mayocp.2019.12.010

In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

Julian A. Marin-Acevedo, Razvan M. Chirila, Roxana Dronca

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	615
Number of pages	1
Journal	Mayo Clinic proceedings
Volume	95
Issue number	3
DOIs	https://doi.org/10.1016/j.mayocp.2019.12.010
State	Published - Mar 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mayocp.2019.12.010

Cite this

@article{6b7d7acbdfd745b6ac7788127e267b6e,

title = "In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk",

author = "Marin-Acevedo, {Julian A.} and Chirila, {Razvan M.} and Roxana Dronca",

year = "2020",

month = mar,

doi = "10.1016/j.mayocp.2019.12.010",

language = "English (US)",

volume = "95",

pages = "615",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "3",

}

TY - JOUR

T1 - In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes

T2 - An Underestimated Risk

AU - Marin-Acevedo, Julian A.

AU - Chirila, Razvan M.

AU - Dronca, Roxana

PY - 2020/3

Y1 - 2020/3

UR - http://www.scopus.com/inward/record.url?scp=85079610589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079610589&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2019.12.010

DO - 10.1016/j.mayocp.2019.12.010

M3 - Letter

C2 - 32138892

AN - SCOPUS:85079610589

SN - 0025-6196

VL - 95

SP - 615

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 3

ER -

In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this